Lanoxin Injection, Solution
NDC Package 70515-261-10
Package Information
Lanoxin (digoxin) injection is digoxin is used to treat heart failure, usually along with other medications. This formulation utilizes a injection, solution delivery system. Marketed by Covis Pharma Us, Inc, this product is identified by NDC 70515-261 and is authorized under FDA application NDA009330.
Identification & Billing
- RxCUI: 104208 - digoxin 500 MCG in 2 ML Injection
- RxCUI: 104208 - 2 ML digoxin 0.25 MG/ML Injection
- RxCUI: 104208 - digoxin 500 MCG per 2 ML Injection
- RxCUI: 204504 - digoxin 100 MCG in 1 ML Injection
- RxCUI: 204504 - 1 ML digoxin 0.1 MG/ML Injection
Clinical Specifications
- Intramuscular - Administration within a muscle.
- Intravenous - Administration within or into a vein or veins.
Regulatory & Marketing
Hierarchy Structure
- 70515 - Covis Pharma Us, Inc
- 70515-261 - Lanoxin
- 70515-261-10 - 10 VIAL in 1 BOX / 2 mL in 1 VIAL
- 70515-261 - Lanoxin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70515-261-10 identifies a specific commercial package of 10 vial in 1 box / 2 ml in 1 vial of Lanoxin, a human prescription drug labeled by Covis Pharma Us, Inc. This injection, solution is formulated for intramuscular; intravenous use and contains digoxin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Covis Pharma Us, Inc on October 29, 2019. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Digoxin is used to treat heart failure, usually along with other medications. It is also used to treat certain types of irregular heartbeat (such as chronic atrial fibrillation). Treating heart failure may help maintain your ability to walk and exercise and may improve the strength of your heart. Treating an irregular heartbeat can also improve your ability to exercise. Digoxin belongs to a class of medications called cardiac glycosides. It works by affecting certain minerals (sodium and potassium) inside heart cells. This reduces strain on the heart and helps it maintain a normal, steady, and strong heartbeat.
How is this Covis Pharma Us, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70515026110. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
